DANIEL M. JUNIUS - 18 May 2021 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role: Director
Signature: /s/ Brian F. Leaf, attorney-in-fact
Issuer symbol: GLYC
Transactions as of: 18 May 2021
Net transactions value: $0
Form type: 4
Filing time: 27 May 2021, 20:58:08 UTC
Previous filing: 14 May 2021
Next filing: 24 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GLYC	Common Stock	Award	$0	+5,250	+14%	$0.000000	43,250	18 May 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GLYC	Stock Option (right to buy)	Award	$0	+10,500		$0.000000	10,500	18 May 2021	Common Stock	10,500	$2.55	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
F2	The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date.
F3	The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date.